Full Press Release Details
Therapeutics Limited (ASX: ATH) - Trading Halt
securities of Alterity Therapeutics Limited ( ATH') will be placed in trading halt at the request of ATH, pending it releasing
an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal
trading on Wednesday, 22 November 2023 or when the announcement is released to the market.
Adviser, Listings Compliance
| 20 November 2023 | Market Announcement 1/1 |
| ASX Limited | ASX Customer Service Centre 131 279 | asx.com.au |
Adviser, Listings Compliance (Melbourne)
ASX Compliance Pty Ltd
50, South Tower, Rialto
for a trading halt - Alterity Therapeutics Limited
accordance with ASX Listing Rule 17.1, Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (the Company) requests that its
securities be placed into an immediate trading halt pending an announcement in relation to a capital raise.
Company requests that trading in its securities be halted until after the expected announcement is made or until the market opens on
Wednesday, 22 November 2023, whichever is the earlier.
Company is not aware of any reason why this trading halt request should not be granted or of any other information necessary to inform
the market about the trading halt.
contact me if you require any further information.
Therapeutics Limited ABN 37 080 699 065
14, 350 Collins Street, Melbourne, VIC 3000 Australia
+61 (0)3 9349 4906 | www.alteritytherapeutics.com